For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251119:nRSS0749Ia&default-theme=true
RNS Number : 0749I Cambridge Nutritional Sciences PLC 19 November 2025
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Director/PDMR Shareholding
CNS (AIM: CNSL), the specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and
nutrition, announces that it has received notification that Carolyn Rand,
Non-Executive Chair of the Company, has purchased 150,000 ordinary shares of 4
pence each in the Company ("Ordinary Shares"), at an average price of 2.32
pence each. Jeremy Millard, Non-Executive Director of the Company, has also
purchased 168,776 Ordinary Shares in the Company, at a price of 2.37 pence
each.
A summary of Carolyn Rand and Jeremy Millard's resultant holdings is below:
Director Board Position Number of Ordinary Shares acquired Total beneficial holding of Ordinary Shares following this acquisition
Number of Ordinary Shares Approximate % of Company's issued share capital
Carolyn Rand Non-Executive Chair 150,000 347,500 0.14%
Jeremy Millard Non-Executive Director 168,776 1,193,776 0.50%
Contacts:
Cambridge Nutritional Sciences plc www.cnsplc.com (http://www.cnsplc.com/)
Carolyn Rand, Non-Executive Chair
James Cooper, Interim Chief Executive
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash / Edward Whiley (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial
responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Carolyn Rand
2 Reason for the notification
a) Position/status Non-Executive Chair
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cambridge Nutritional Sciences plc
b) LEI 2138007U9P4BTZTYIR92
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 4 pence each
Identification code
ISIN: GB00B1VCP282
b) Nature of the transaction Ordinary Shares purchased
c) Price(s) and volume(s)
Price(s) Volume(s)
2.30 pence 100,000
2.365 pence 50,000
d) Aggregated information
-Aggregated volume Aggregated volume - 150,000
- Price
Price - 2.3216
e) Date of the transaction 18.11.2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
-Aggregated volume
- Price
Aggregated volume - 150,000
Price - 2.3216
e)
Date of the transaction
18.11.2025
f)
Place of the transaction
London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jeremy Millard
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Cambridge Nutritional Sciences plc
b) LEI 2138007U9P4BTZTYIR92
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 4 pence each
Identification code
ISIN: GB00B1VCP282
b) Nature of the transaction Ordinary Shares purchased
c) Price(s) and volume(s)
Price(s) Volume(s)
2.37 pence 168,776
d) Aggregated information
-Aggregated volume As above.
- Price
e) Date of the transaction 18.11.2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
-Aggregated volume
- Price
As above.
e)
Date of the transaction
18.11.2025
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDGBDBIXBDGUI
Copyright 2019 Regulatory News Service, all rights reserved